Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 123

1.

Toll like receptor 2 and 9 expression on circulating neutrophils is associated with increased mortality in critically ill patients.

Lenz M, Draxler DF, Zhang C, Kassem M, Kastl SP, Niessner A, Huber K, Wojta J, Heinz G, Speidl WS, Krychtiuk KA.

Shock. 2019 Nov 4. doi: 10.1097/SHK.0000000000001467. [Epub ahead of print]

PMID:
31688663
2.

Oral Anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1.

Sulzgruber P, Wassmann S, Semb AG, Doehner W, Widimsky P, Gremmel T, Kaski JC, Savarese G, Rosano GMC, Borghi C, Kjeldsen K, Torp-Pedersen C, Schmidt TA, Lewis BS, Drexel H, Tamargo J, Atar D, Agewall S, Niessner A.

Eur Heart J. 2019 Sep 21;40(36):3010-3012. doi: 10.1093/eurheartj/ehz650. No abstract available.

PMID:
31541549
3.

Response to: Current opinion of the ESC Working Group on Cardiovascular Pharmacotherapy and ESC Council on Stroke.

Sulzgruber P, Niessner A.

Eur Heart J Cardiovasc Pharmacother. 2019 Aug 26. pii: pvz040. doi: 10.1093/ehjcvp/pvz040. [Epub ahead of print] No abstract available.

PMID:
31504397
4.

Lipid management in rheumatoid arthritis: a position paper by the Cardiovascular Pharmacotherapy Working Group of European Society of Cardiology.

Hollan I, Ronda N, Dessein P, Agewall S, Karpouzas G, Tamargo J, Niessner A, Savarese G, Rosano G, Kaski JC, Wassmann S, Meroni PL.

Eur Heart J Cardiovasc Pharmacother. 2019 Aug 9. pii: pvz033. doi: 10.1093/ehjcvp/pvz033. [Epub ahead of print]

PMID:
31397840
5.

Antithrombotic Therapy and Major Adverse Limb Events in Patients With Chronic Lower Extremity Arterial Disease: Systematic Review and Meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta & Peripheral Vascular Diseases.

Savarese G, Reiner MF, Uijl A, D Amario D, Agewall S, Atar D, Baumgartner I, Borghi C, De Carlo M, Drexel H, Kaski JC, Kjeldsen KP, Kucher N, Lund LH, Niessner A, Semb AG, Schmidt TA, Sulzgruber P, Tamargo J, Vitale C, Wassmann S, Aboyans V, Lewis BS.

Eur Heart J Cardiovasc Pharmacother. 2019 Aug 8. pii: pvz036. doi: 10.1093/ehjcvp/pvz036. [Epub ahead of print]

PMID:
31392312
6.

The age of RCT`s 3 Important Aspects of RCT`s in Cardiovascular Pharmacotherapy with examples from Lipid and Diabetes Trials.

Drexel H, Rosano GMC, Lewis BS, Huber K, Vonbank A, Dopheide JF, Mader A, Niessner A, Savarese G, Wassmann S, Agewall S.

Eur Heart J Cardiovasc Pharmacother. 2019 Jul 12. pii: pvz029. doi: 10.1093/ehjcvp/pvz029. [Epub ahead of print] No abstract available.

PMID:
31298686
7.

Critical appraisal of the AUGUSTUS trial.

Gremmel T, Sulzgruber P, Niessner A.

Eur Heart J Cardiovasc Pharmacother. 2019 Oct 1;5(4):187-188. doi: 10.1093/ehjcvp/pvz017. No abstract available.

PMID:
31265054
8.

Bleeding and ischaemic outcomes in patients treated with dual or triple antithrombotic therapy: systematic review and meta-analysis.

Haller PM, Sulzgruber P, Kaufmann C, Geelhoed B, Tamargo J, Wassmann S, Schnabel RB, Westermann D, Huber K, Niessner A, Gremmel T.

Eur Heart J Cardiovasc Pharmacother. 2019 Oct 1;5(4):226-236. doi: 10.1093/ehjcvp/pvz021.

PMID:
31198930
9.

Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: a current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke.

Sulzgruber P, Wassmann S, Semb AG, Doehner W, Widimsky P, Gremmel T, Kaski JC, Savarese G, Rosano GMC, Borghi C, Kjeldsen K, Torp-Pedersen C, Schmidt TA, Lewis BS, Drexel H, Tamargo J, Atar D, Agewall S, Niessner A.

Eur Heart J Cardiovasc Pharmacother. 2019 Jul 1;5(3):171-180. doi: 10.1093/ehjcvp/pvz016.

PMID:
31119266
10.

Aortic stenosis is an independent predictor for outcome in patients with in-hospital cardiac arrest.

Sulzgruber P, Schnaubelt S, Pesce M, Uray T, Niederdöckl J, Domanovits H, Rosenhek R, Binder T, Distelmaier K, Hengstenberg C, Niessner A, Goliasch G.

Resuscitation. 2019 Apr;137:156-160. doi: 10.1016/j.resuscitation.2019.01.037. Epub 2019 Feb 25.

PMID:
30818015
11.

Correction to: Non-vitamin K antagonist oral anticoagulants in patients with an increased risk of bleeding.

Gremmel T, Niessner A, Domanovits H, Frossard M, Sengölge G, Steinlechner B, Sycha T, Wolzt M, Pabinger I.

Wien Klin Wochenschr. 2019 Mar;131(5-6):135. doi: 10.1007/s00508-019-1467-8.

12.

Discriminatory power of scoring systems for outcome prediction in patients with extracorporeal membrane oxygenation following cardiovascular surgery†.

Schrutka L, Rohmann F, Binder C, Haberl T, Dreyfuss B, Heinz G, Lang IM, Felli A, Steinlechner B, Niessner A, Laufer G, Goliasch G, Wiedemann D, Distelmaier K.

Eur J Cardiothorac Surg. 2019 Sep 1;56(3):534-540. doi: 10.1093/ejcts/ezz040.

PMID:
30789227
13.

De-Ritis Ratio Improves Long-Term Risk Prediction after Acute Myocardial Infarction.

Steininger M, Winter MP, Reiberger T, Koller L, El-Hamid F, Forster S, Schnaubelt S, Hengstenberg C, Distelmaier K, Goliasch G, Wojta J, Toma A, Niessner A, Sulzgruber P.

J Clin Med. 2018 Nov 23;7(12). pii: E474. doi: 10.3390/jcm7120474.

14.

Non-vitamin K antagonist oral anticoagulants in patients with an increased risk of bleeding.

Gremmel T, Niessner A, Domanovits H, Frossard M, Sengölge G, Steinlechner B, Sycha T, Wolzt M, Pabinger I.

Wien Klin Wochenschr. 2018 Dec;130(23-24):722-734. doi: 10.1007/s00508-018-1381-5. Epub 2018 Aug 20. Erratum in: Wien Klin Wochenschr. 2019 Mar;131(5-6):135.

15.

Oxygenation in post-resuscitation care-how much is too much?

Schnaubelt S, Domanovits H, Niessner A, Sulzgruber P.

J Thorac Dis. 2018 Jul;10(Suppl 18):S2111-S2113. doi: 10.21037/jtd.2018.06.37. No abstract available.

16.

Critical appraisal of the COMPASS trial.

Niessner A, Agewall S.

Eur Heart J Cardiovasc Pharmacother. 2018 Oct 1;4(4):191-192. doi: 10.1093/ehjcvp/pvy027. No abstract available.

PMID:
30113628
17.

Research update for articles published in EJCI in 2016.

Adlbrecht C, Blanco-Verea A, Bouzas-Mosquera MC, Brion M, Burtscher M, Carbone F, Chang TT, Charmandari E, Chen JW, Correia-Costa L, Dullaart RPF, Eleftheriades M, Fernandez-Fernandez B, Goliasch G, Gremmel T, Groeneveld ME, Henrique A, Huelsmann M, Jung C, Lichtenauer M, Montecucco F, Nicolaides NC, Niessner A, Palmeira C, Pirklbauer M, Sanchez-Niño MD, Sotiriadis A, Sousa T, Sulzgruber P, van Beek AP, Veronese N, Winter MP, Yeung KK, Bouzas-Mosquera A.

Eur J Clin Invest. 2018 Oct;48(10):e13016. doi: 10.1111/eci.13016. Epub 2018 Sep 16. Review. No abstract available.

PMID:
30099749
18.

Reasons for disparity in statin adherence rates between clinical trials and real-world observations: a review.

Vonbank A, Drexel H, Agewall S, Lewis BS, Dopheide JF, Kjeldsen K, Ceconi C, Savarese G, Rosano G, Wassmann S, Niessner A, Schmidt TA, Saely CH, Baumgartner I, Tamargo J.

Eur Heart J Cardiovasc Pharmacother. 2018 Oct 1;4(4):230-236. doi: 10.1093/ehjcvp/pvy028. Review. Erratum in: Eur Heart J Cardiovasc Pharmacother. 2019 Jan 1;5(1):36. Eur Heart J Cardiovasc Pharmacother. 2019 Jan 1;5(1):36.

PMID:
30099530
19.

Blood urea nitrogen has additive value beyond estimated glomerular filtration rate for prediction of long-term mortality in patients with acute myocardial infarction.

Richter B, Sulzgruber P, Koller L, Steininger M, El-Hamid F, Rothgerber DJ, Forster S, Goliasch G, Silbert BI, Meyer EL, Hengstenberg C, Wojta J, Niessner A.

Eur J Intern Med. 2019 Jan;59:84-90. doi: 10.1016/j.ejim.2018.07.019. Epub 2018 Jul 30.

PMID:
30072202
20.

CD4+CD28null T Lymphocytes are Associated with the Development of Atrial Fibrillation after Elective Cardiac Surgery.

Sulzgruber P, Thaler B, Koller L, Baumgartner J, Pilz A, Steininger M, Schnaubelt S, Fleck T, Laufer G, Steinlechner B, Winter MP, Goliasch G, Wojta J, Niessner A.

Sci Rep. 2018 Jun 25;8(1):9624. doi: 10.1038/s41598-018-28046-0.

21.

Immunomodulatory treatment for lymphocytic myocarditis-a systematic review and meta-analysis.

Winter MP, Sulzgruber P, Koller L, Bartko P, Goliasch G, Niessner A.

Heart Fail Rev. 2018 Jul;23(4):573-581. doi: 10.1007/s10741-018-9709-9.

22.

Cardiac arrest as an age-dependent prognosticator for long-term mortality after acute myocardial infarction: the potential impact of infarction size.

Sulzgruber P, Schnaubelt S, Koller L, Goliasch G, Niederdöckl J, Simon A, El-Hamid F, Rothgerber DJ, Wojta J, Niessner A.

Eur Heart J Acute Cardiovasc Care. 2019 Mar;8(2):153-160. doi: 10.1177/2048872618781370. Epub 2018 Jun 1.

PMID:
29856229
23.

Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology.

Rosano GMC, Tamargo J, Kjeldsen KP, Lainscak M, Agewall S, Anker SD, Ceconi C, Coats AJS, Drexel H, Filippatos G, Kaski JC, Lund L, Niessner A, Ponikowski P, Savarese G, Schmidt TA, Seferovic P, Wassmann S, Walther T, Lewis BS.

Eur Heart J Cardiovasc Pharmacother. 2018 Jul 1;4(3):180-188. doi: 10.1093/ehjcvp/pvy015.

PMID:
29726985
24.

The "Pectoral-Gap Phenomenon": A Hypothesis on Origin and Mechanism.

Schnaubelt S, Neophytou G, Richter B, Domanovits H, Niessner A, Sulzgruber P.

Sports Med. 2018 Aug;48(8):1987-1988. doi: 10.1007/s40279-018-0886-4. No abstract available.

PMID:
29508372
25.

Duration of extracorporeal membrane oxygenation support and survival in cardiovascular surgery patients.

Distelmaier K, Wiedemann D, Binder C, Haberl T, Zimpfer D, Heinz G, Koinig H, Felli A, Steinlechner B, Niessner A, Laufer G, Lang IM, Goliasch G.

J Thorac Cardiovasc Surg. 2018 Jun;155(6):2471-2476. doi: 10.1016/j.jtcvs.2017.12.079. Epub 2017 Dec 26.

PMID:
29395201
26.

Trimethylamine-N-oxide and Heart Failure With Reduced Versus Preserved Ejection Fraction.

Schuett K, Kleber ME, Scharnagl H, Lorkowski S, März W, Niessner A, Marx N, Meinitzer A.

J Am Coll Cardiol. 2017 Dec 26;70(25):3202-3204. doi: 10.1016/j.jacc.2017.10.064. No abstract available.

27.

Non-insulin antidiabetic pharmacotherapy in patients with established cardiovascular disease: a position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.

Niessner A, Tamargo J, Koller L, Saely CH, Schmidt TA, Savarese G, Wassmann S, Rosano G, Ceconi C, Torp-Pedersen C, Kaski JC, Kjeldsen KP, Agewall S, Walther T, Drexel H, Lewis BS.

Eur Heart J. 2018 Jun 21;39(24):2274-2281. doi: 10.1093/eurheartj/ehx625. No abstract available.

PMID:
29126266
28.

Changing paradigms in oral anticoagulation during cardioversion in Europe.

Sulzgruber P, Niessner A.

Eur Heart J Cardiovasc Pharmacother. 2018 Jan 1;4(1):2-3. doi: 10.1093/ehjcvp/pvx025. No abstract available.

PMID:
29036281
29.

Impact of Right Ventricular Performance in Patients Undergoing Extracorporeal Membrane Oxygenation Following Cardiac Surgery.

Bartko PE, Wiedemann D, Schrutka L, Binder C, Santos-Gallego CG, Zuckermann A, Steinlechner B, Koinig H, Heinz G, Niessner A, Zimpfer D, Laufer G, Lang IM, Distelmaier K, Goliasch G.

J Am Heart Assoc. 2017 Jul 28;6(8). pii: e005455. doi: 10.1161/JAHA.116.005455.

30.

Refining Long-Term Prediction of Cardiovascular Risk in Diabetes - The VILDIA Score.

Goliasch G, Silbernagel G, Kleber ME, Grammer TB, Pilz S, Tomaschitz A, Bartko PE, Maurer G, Koenig W, Niessner A, März W.

Sci Rep. 2017 Jul 5;7(1):4700. doi: 10.1038/s41598-017-04935-8.

31.

Clusterin/apolipoprotein J is independently associated with survival in patients with chronic heart failure.

Koller L, Richter B, Winter MP, Sulzgruber P, Potolidis C, Liebhart F, Mörtl D, Berger R, Goliasch G, Lang I, Wojta J, Hülsmann M, Niessner A.

J Clin Lipidol. 2017 Jan - Feb;11(1):178-184. doi: 10.1016/j.jacl.2016.11.009. Epub 2016 Dec 7.

PMID:
28391884
32.

Soluble Urokinase-Type Plasminogen Activator Receptor Improves Risk Prediction in Patients With Chronic Heart Failure.

Koller L, Stojkovic S, Richter B, Sulzgruber P, Potolidis C, Liebhart F, Mörtl D, Berger R, Goliasch G, Wojta J, Hülsmann M, Niessner A.

JACC Heart Fail. 2017 Apr;5(4):268-277. doi: 10.1016/j.jchf.2016.12.008.

33.

Gender differences in the effects of cardiovascular drugs.

Tamargo J, Rosano G, Walther T, Duarte J, Niessner A, Kaski JC, Ceconi C, Drexel H, Kjeldsen K, Savarese G, Torp-Pedersen C, Atar D, Lewis BS, Agewall S.

Eur Heart J Cardiovasc Pharmacother. 2017 Jul 1;3(3):163-182. doi: 10.1093/ehjcvp/pvw042. Review.

PMID:
28329228
34.

ESC working group position paper on myocardial infarction with non-obstructive coronary arteries.

Agewall S, Beltrame JF, Reynolds HR, Niessner A, Rosano G, Caforio AL, De Caterina R, Zimarino M, Roffi M, Kjeldsen K, Atar D, Kaski JC, Sechtem U, Tornvall P; WG on Cardiovascular Pharmacotherapy.

Eur Heart J. 2017 Jan 14;38(3):143-153. doi: 10.1093/eurheartj/ehw149. No abstract available.

PMID:
28158518
35.

Comprehensive efforts to increase adherence to statin therapy.

Vonbank A, Agewall S, Kjeldsen KP, Lewis BS, Torp-Pedersen C, Ceconi C, Funck-Brentano C, Kaski JC, Niessner A, Tamargo J, Walther T, Wassmann S, Rosano G, Schmidt H, Saely CH, Drexel H.

Eur Heart J. 2017 Aug 21;38(32):2473-2479. doi: 10.1093/eurheartj/ehw628. No abstract available.

PMID:
28077470
36.

Impaired High-Density Lipoprotein Anti-Oxidative Function Is Associated With Outcome in Patients With Chronic Heart Failure.

Schrutka L, Distelmaier K, Hohensinner P, Sulzgruber P, Lang IM, Maurer G, Wojta J, Hülsmann M, Niessner A, Koller L.

J Am Heart Assoc. 2016 Dec 21;5(12). pii: e004169. doi: 10.1161/JAHA.116.004169.

37.

Prognostic significance of tPA/PAI-1 complex in patients with heart failure and preserved ejection fraction.

Winter MP, Kleber ME, Koller L, Sulzgruber P, Scharnagl H, Delgado G, Goliasch G, März W, Niessner A.

Thromb Haemost. 2017 Feb 28;117(3):471-478. doi: 10.1160/TH16-08-0600. Epub 2016 Dec 15.

PMID:
27975104
38.

The impact of CD4+CD28null T-lymphocytes on atrial fibrillation and mortality in patients with chronic heart failure.

Sulzgruber P, Koller L, Winter MP, Richter B, Blum S, Korpak M, Hülsmann M, Goliasch G, Wojta J, Niessner A.

Thromb Haemost. 2017 Jan 26;117(2):349-356. doi: 10.1160/TH16-07-0531. Epub 2016 Dec 1.

PMID:
27904907
39.

Long-term outcome and risk prediction in patients suffering acute myocardial infarction complicated by post-infarction cardiac rupture.

Sulzgruber P, El-Hamid F, Koller L, Forster S, Goliasch G, Wojta J, Niessner A.

Int J Cardiol. 2017 Jan 15;227:399-403. doi: 10.1016/j.ijcard.2016.11.037. Epub 2016 Nov 7.

PMID:
27847155
40.

Monocyte subset distribution is associated with mortality in critically ill patients.

Krychtiuk KA, Lenz M, Koller L, Honeder MC, Wutzlhofer L, Zhang C, Chi L, Maurer G, Niessner A, Huber K, Wojta J, Heinz G, Speidl WS.

Thromb Haemost. 2016 Oct 28;116(5):949-957. Epub 2016 Sep 8.

PMID:
27604519
41.

Double or triple antithrombotic combination therapy in patients who need anticoagulation and antiplatelet therapy in parallel.

Rohla M, Weiss TW, Wojta J, Niessner A, Huber K.

Eur Heart J Cardiovasc Pharmacother. 2015 Jul;1(3):191-7. doi: 10.1093/ehjcvp/pvv014. Epub 2015 Mar 19. Review.

PMID:
27533995
42.

Did referral patterns for coronary angiography change in Europe? What can we learn from Denmark?

Koller L, Niessner A.

Eur Heart J Cardiovasc Pharmacother. 2015 Jul;1(3):166-7. doi: 10.1093/ehjcvp/pvv013. Epub 2015 Mar 4. No abstract available. Erratum in: Eur Heart J Cardiovasc Pharmacother. 2016 Oct;2(4):217.

PMID:
27533990
43.

Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology.

Schmidt M, Lamberts M, Olsen AM, Fosbøll EL, Niessner A, Tamargo J, Rosano G, Agewall S, Kaski JC, Kjeldsen K, Lewis BS, Torp-Pedersen C.

Eur Heart J Cardiovasc Pharmacother. 2016 Apr;2(2):108-18. doi: 10.1093/ehjcvp/pvv054. No abstract available. Erratum in: Eur Heart J Cardiovasc Pharmacother. 2017 Apr 1;3(2):124. Fosbøl, Emil [corrected to Fosbøl, Emil L].

PMID:
27533522
44.

Prognostic relevance of circulating endothelial progenitor cells in patients with chronic heart failure.

Koller L, Hohensinner P, Sulzgruber P, Blum S, Maurer G, Wojta J, Hülsmann M, Niessner A.

Thromb Haemost. 2016 Aug 1;116(2):309-16. doi: 10.1160/TH16-01-0051. Epub 2016 Jun 2.

PMID:
27412580
45.

2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).

Authors/Task Force Members, Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corrà U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FD, Løchen ML, Löllgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van der Worp HB, van Dis I, Verschuren WM; Additional Contributor: Simone Binno (Italy); Document Reviewers:, De Backer G, Roffi M, Aboyans V, Bachl N, Bueno H, Carerj S, Cho L, Cox J, De Sutter J, Egidi G, Fisher M, Fitzsimons D, Franco OH, Guenoun M, Jennings C, Jug B, Kirchhof P, Kotseva K, Lip GY, Mach F, Mancia G, Bermudo FM, Mezzani A, Niessner A, Ponikowski P, Rauch B, Rydén L, Stauder A, Turc G, Wiklund O, Windecker S, Zamorano JL.

Eur J Prev Cardiol. 2016 Jul;23(11):NP1-NP96. doi: 10.1177/2047487316653709. Epub 2016 Jun 27. No abstract available.

PMID:
27353126
46.

Beneficial effects of levosimendan on survival in patients undergoing extracorporeal membrane oxygenation after cardiovascular surgery.

Distelmaier K, Roth C, Schrutka L, Binder C, Steinlechner B, Heinz G, Lang IM, Maurer G, Koinig H, Niessner A, Hülsmann M, Speidl W, Goliasch G.

Br J Anaesth. 2016 Jul;117(1):52-8. doi: 10.1093/bja/aew151.

47.

Cardiac arrest does not affect survival in post-operative cardiovascular surgery patients undergoing extracorporeal membrane oxygenation.

Distelmaier K, Schrutka L, Binder C, Steinlechner B, Heinz G, Lang IM, Ristl R, Maurer G, Koinig H, Wiedemann D, Rützler K, Niessner A, Goliasch G.

Resuscitation. 2016 Jul;104:24-7. doi: 10.1016/j.resuscitation.2016.03.028. Epub 2016 Apr 21.

PMID:
27109504
48.

Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology.

Schmidt M, Lamberts M, Olsen AM, Fosbøll E, Niessner A, Tamargo J, Rosano G, Agewall S, Kaski JC, Kjeldsen K, Lewis BS, Torp-Pedersen C.

Eur Heart J. 2016 Apr 1;37(13):1015-23. doi: 10.1093/eurheartj/ehv505. Epub 2016 Mar 16. Review. No abstract available.

PMID:
26984863
49.

Liver function predicts survival in patients undergoing extracorporeal membrane oxygenation following cardiovascular surgery.

Roth C, Schrutka L, Binder C, Kriechbaumer L, Heinz G, Lang IM, Maurer G, Koinig H, Steinlechner B, Niessner A, Distelmaier K, Goliasch G.

Crit Care. 2016 Mar 11;20:57. doi: 10.1186/s13054-016-1242-4.

50.

Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management-a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Working Group on Thrombosis.

Niessner A, Tamargo J, Morais J, Koller L, Wassmann S, Husted SE, Torp-Pedersen C, Kjeldsen K, Lewis BS, Drexel H, Kaski JC, Atar D, Storey RF, Lip GYH, Verheugt FWA, Agewall S.

Eur Heart J. 2017 Jun 7;38(22):1710-1716. doi: 10.1093/eurheartj/ehv676. No abstract available.

PMID:
26705385

Supplemental Content

Loading ...
Support Center